{"grounding": "After a traumatic childhood in Europe during the Second World War, I found that scientific research in Israel was a pleasure beyond my expectations. Over the last 65 year, I have worked on the chemistry and pharmacology of natural products. During the last few decades, most of my research has been on plant cannabinoids, the endogenous cannabinoids arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol, and endogenous anandamide-like compounds, all of which are involved in a wide spectrum of physiological reactions. Two plant cannabinoids, Δ9-tetrahydrocannabinol and cannabidiol, are approved drugs. However, the endogenous cannabinoids and the anandamide-like constituents have not yet been well investigated in humans. For me, intellectual freedom—the ability to do research based on my own scientific interests—has been the most satisfying part of my working life. Looking back over the 91 years of my long life, I conclude that I have been lucky, very lucky, both personally and scientifically.", "generated_text": "This autobiographical exploration delves into the intricate world of cannabinoid and endocannabinoid chemistry and pharmacology, offering a personal journey through the discovery and understanding of key compounds such as anandamide, 2-arachidonoylglycerol (2-AG), tetrahydrocannabinol (THC), and cannabidiol (CBD). It highlights the pivotal moments and breakthroughs in the field, from the initial identification of these molecules to their complex roles in the human body's endocannabinoid system. The narrative also touches upon the discovery and significance of endocannabinoid-like compounds, shedding light on their potential therapeutic applications. Through this personal account, the abstract aims to provide insights into the challenges and triumphs encountered in cannabinoid research, emphasizing the importance of these compounds in advancing our understanding of human physiology and pharmacology.", "label": 0}